These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35242185)

  • 1. lncRNA RUNDC3A-AS1 Regulates Proliferation and Apoptosis of Thyroid Cancer Cells via the miR-151b/SNRPB Axis.
    Deng Y; Wu J; Li X
    Int J Endocrinol; 2022; 2022():9433434. PubMed ID: 35242185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA ATP1A1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620/IRF2BP2 axis.
    Jia J; Liu Y; Yang X; Wu Z; Xu X; Kang F; Liu Y
    Am J Med Sci; 2023 Jan; 365(1):73-83. PubMed ID: 36002076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-coding RNA RUNDC3A-AS1 Promotes Lung Metastasis of Thyroid Cancer via Targeting the miR-182-5p/ADAM9.
    Ma D; Zhu Y; Zhang X; Zhang J; Chen W; Chen X; Qian Y; Zhao Y; Hu T; Yao Z; Zhao W; Zhang Y; Liu F
    Front Cell Dev Biol; 2021; 9():650004. PubMed ID: 34046406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMCD1 antisense RNA 1 (LMCD1-AS1) potentiates thyroid cancer cell growth and stemness via a positive feedback loop of LMCD1-AS1/miR-1287-5p/GLI2.
    Shao J; Xu Y; Li H; Chen L; Wang W; Shen D; Chen J
    Ann Transl Med; 2020 Nov; 8(22):1508. PubMed ID: 33313253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PAX8-AS1 Inhibits Malignant Phenotypes of Papillary Thyroid Carcinoma Cells via miR-96-5p/PKN2 Axis.
    Zhou P; Xu T; Hu H; Hua F
    Int J Endocrinol; 2021; 2021():5499963. PubMed ID: 34745257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEF-AS1 participates in occurrence of colorectal cancer through adsorbing miR-505 and promoting KIF3B expression.
    Gong XY; Huang AL
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9362-9370. PubMed ID: 31773695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
    Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
    Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
    Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
    Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
    J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.
    Guo H; Lin S; Gan Z; Xie J; Zhou J; Hu M
    Oncol Lett; 2021 Dec; 22(6):853. PubMed ID: 34733371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis.
    Fu D; Lu C; Qu X; Li P; Chen K; Shan L; Zhu X
    Aging (Albany NY); 2019 Oct; 11(19):8374-8385. PubMed ID: 31600142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
    Liu X; Shen Z
    Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
    Huang JW; Luo XY; Li ZH; Lang BP
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA ZEB1-AS1 facilitates ox-LDL-induced damage of HCtAEC cells and the oxidative stress and inflammatory events of THP-1 cells via miR-942/HMGB1 signaling.
    Hua Z; Ma K; Liu S; Yue Y; Cao H; Li Z
    Life Sci; 2020 Apr; 247():117334. PubMed ID: 31962131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA SLCO4A1-AS1/miR-876-3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway.
    Mao J; Gao W; Xue L; Wang J; Zhao L
    Int J Lab Hematol; 2021 Oct; 43(5):1050-1061. PubMed ID: 33683013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis.
    Ding M; Fu Y; Guo F; Chen H; Fu X; Tan W; Zhang H
    Int J Clin Exp Pathol; 2020; 13(10):2455-2473. PubMed ID: 33165437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis.
    Zhang C; Yang H; Li Y; Huo P; Ma P
    Mol Cell Biochem; 2020 Apr; 467(1-2):15-25. PubMed ID: 32072428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.